BCM
AIMT

Bridgeway Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bridgeway Capital Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,600
Closed -$378K – 1382
2020
Q2 		$378K Buy
+22,600
New +$378K 0.01% 954